{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:21:34Z","timestamp":1782894094245,"version":"3.54.5"},"reference-count":68,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2014,10,21]]},"published-print":{"date-parts":[[2015,1,1]]},"abstract":"<jats:p>Resistant hypertension continues to pose a major challenge to clinicians worldwide and has serious implications for patients who are at increased risk of cardiovascular morbidity and mortality with this diagnosis. Pharmacological therapy for resistant hypertension follows guidelines-based regimens although there is surprisingly scant evidence for beneficial outcomes using additional drug treatment after three antihypertensives have failed to achieve target blood pressure. Recently there has been considerable interest in the use of endoluminal renal denervation as an interventional technique to achieve renal nerve ablation and lower blood pressure. Although initial clinical trials of renal denervation in patients with resistant hypertension demonstrated encouraging office blood pressure reduction, a large randomised control trial (Symplicity HTN-3) with a sham-control limb, failed to meet its primary efficacy end point. The trial however was subject to a number of flaws which must be taken into consideration in interpreting the final results. Moreover a substantial body of evidence from non-randomised smaller trials does suggest that renal denervation may have an important role in the management of hypertension and other disease states characterised by overactivation of the sympathetic nervous system. The Joint UK Societies does not recommend the use of renal denervation for treatment of resistant hypertension in routine clinical practice but remains committed to supporting research activity in this field. A number of research strategies are identified and much that can be improved upon to ensure better design and conduct of future randomised studies.<\/jats:p>","DOI":"10.1136\/heartjnl-2014-307029","type":"journal-article","created":{"date-parts":[[2014,11,28]],"date-time":"2014-11-28T10:54:30Z","timestamp":1417172070000},"page":"10-16","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":39,"title":["Joint UK societies\u2019 2014 consensus statement on renal denervation for resistant hypertension"],"prefix":"10.1136","volume":"101","author":[{"given":"Melvin D","family":"Lobo","sequence":"first","affiliation":[{"name":"On behalf of the British Hypertension Society"},{"name":"Barts NIHR Cardiovascular Biomedical Research Unit, William Harvey Research Institute, Queen Mary University of London, London, UK"},{"name":"Department of Cardiovascular Medicine, Barts Health NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A","family":"de Belder","sequence":"additional","affiliation":[{"name":"The British Cardiovascular Society"},{"name":"The British Cardiovascular Intervention Society"},{"name":"Cardiothoracic Division, The James Cook University Hospital, Middlesbrough, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Cleveland","sequence":"additional","affiliation":[{"name":"The British Society for Interventional Radiology"},{"name":"Sheffield Vascular Institute, Sheffield Teaching Hospitals NHSFT, Northern General Hospital, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Collier","sequence":"additional","affiliation":[{"name":"On behalf of the British Hypertension Society"},{"name":"Barts NIHR Cardiovascular Biomedical Research Unit, William Harvey Research Institute, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indranil","family":"Dasgupta","sequence":"additional","affiliation":[{"name":"The Renal Association"},{"name":"Department of Renal Medicine, Birmingham Heartlands Hospital, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Deanfield","sequence":"additional","affiliation":[{"name":"Cardiothoracic Division, The James Cook University Hospital, Middlesbrough, UK"},{"name":"The National Institute for Cardiovascular Outcomes Research, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Kapil","sequence":"additional","affiliation":[{"name":"On behalf of the British Hypertension Society"},{"name":"Barts NIHR Cardiovascular Biomedical Research Unit, William Harvey Research Institute, Queen Mary University of London, London, UK"},{"name":"Department of Cardiovascular Medicine, Barts Health NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Knight","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Barts Health NHS Trust, London, UK"},{"name":"The British Cardiovascular Society"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Matson","sequence":"additional","affiliation":[{"name":"The British Society for Interventional Radiology"},{"name":"Barts NIHR Cardiovascular Biomedical Research Unit, William Harvey Research Institute, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Moss","sequence":"additional","affiliation":[{"name":"The British Society for Interventional Radiology"},{"name":"Interventional Radiology Unit, Gartnavel General Hospital, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian F R","family":"Paton","sequence":"additional","affiliation":[{"name":"On behalf of the British Hypertension Society"},{"name":"School of Physiology & Pharmacology, Bristol Cardiovascular Medical Sciences Building, University of Bristol, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Poulter","sequence":"additional","affiliation":[{"name":"On behalf of the British Hypertension Society"},{"name":"International Centre for Circulatory Health, Imperial College, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Simpson","sequence":"additional","affiliation":[{"name":"The British Cardiovascular Society"},{"name":"Wessex Regional Cardiac Unit, University Hospital Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Williams","sequence":"additional","affiliation":[{"name":"On behalf of the British Hypertension Society"},{"name":"Institute of Cardiovascular Sciences, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J","family":"Caulfield","sequence":"additional","affiliation":[{"name":"On behalf of the British Hypertension Society"},{"name":"Barts NIHR Cardiovascular Biomedical Research Unit, William Harvey Research Institute, Queen Mary University of London, London, UK"},{"name":"Department of Cardiovascular Medicine, Barts Health NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2014,11,27]]},"reference":[{"key":"2025092002363780000_101.1.10.1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.068064"},{"key":"2025092002363780000_101.1.10.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2005.05.014"},{"key":"2025092002363780000_101.1.10.3","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.170308"},{"key":"2025092002363780000_101.1.10.4","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.168948"},{"key":"2025092002363780000_101.1.10.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60566-3"},{"key":"2025092002363780000_101.1.10.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62039-9"},{"key":"2025092002363780000_101.1.10.7","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.163014"},{"key":"2025092002363780000_101.1.10.8","unstructured":"Medtronic Announces U.S. Renal Denervation Pivotal Trial Fails to Meet Primary Efficacy Endpoint While Meeting Primary Safety Endpoint [press release]. 09\/01\/2014 2014."},{"key":"2025092002363780000_101.1.10.9","unstructured":"Caulfield M , de Belder M , Cleveland T , et al . The Joint UK Societies Working Group on Renal Denervation. Initial response to the Medtronic Symplicity HTN3 announcement. 2014. http:\/\/www.bhsoc.org\/files\/2913\/9084\/2931\/The_Joint_UK_Societies_Working_Group_on_Renal_Denervation_Statement_on_Symplicity_HTN3_pre-final.pdf"},{"key":"2025092002363780000_101.1.10.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402670"},{"key":"2025092002363780000_101.1.10.11","unstructured":"Catheter-Based Renal Denervation for Resistant Hypertension: Rationale and Design of the SYMPLICITY HTN-3 Trial. 2012."},{"key":"2025092002363780000_101.1.10.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.08.1002"},{"key":"2025092002363780000_101.1.10.13","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328362152e"},{"key":"2025092002363780000_101.1.10.14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.000949"},{"key":"2025092002363780000_101.1.10.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.06.023"},{"key":"2025092002363780000_101.1.10.16","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.24557"},{"key":"2025092002363780000_101.1.10.17","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht141"},{"key":"2025092002363780000_101.1.10.18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.15420\/icr.2011.9.1.54","article-title":"Renal sympathetic denervation\u2014a review of applications in current practice","volume":"9","author":"Kapil","year":"2014","journal-title":"Intervent Cardiol Rev"},{"key":"2025092002363780000_101.1.10.19","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1097\/HJH.0000000000000323","article-title":"Renal artery stenosis following renal denervation: a matter of concern","volume":"32","author":"Persu","year":"2014","journal-title":"J Hypertens"},{"key":"2025092002363780000_101.1.10.20","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht197"},{"key":"2025092002363780000_101.1.10.21","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpu096"},{"key":"2025092002363780000_101.1.10.22","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.01261"},{"key":"2025092002363780000_101.1.10.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.07.046"},{"key":"2025092002363780000_101.1.10.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.05.036"},{"key":"2025092002363780000_101.1.10.25","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.00095"},{"key":"2025092002363780000_101.1.10.26","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpu048"},{"key":"2025092002363780000_101.1.10.27","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpu036"},{"key":"2025092002363780000_101.1.10.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62192-3"},{"key":"2025092002363780000_101.1.10.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.06.079"},{"key":"2025092002363780000_101.1.10.30","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV9I10A190"},{"key":"2025092002363780000_101.1.10.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.09.027"},{"key":"2025092002363780000_101.1.10.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61145-3"},{"key":"2025092002363780000_101.1.10.33","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.112.195263"},{"key":"2025092002363780000_101.1.10.34","unstructured":"Kapil V , Lobo MD . Clinical Considerations and the Potential for Renal Denervation. Endovascular Today [Internet] 2013; 10:[1\u20137 pp.]. http:\/\/evtoday.com\/pdfs\/et1013_F3_Lobo.pdf"},{"key":"2025092002363780000_101.1.10.35","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.03194"},{"key":"2025092002363780000_101.1.10.36","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpt132"},{"key":"2025092002363780000_101.1.10.37","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3283658ef7"},{"key":"2025092002363780000_101.1.10.38","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.03246"},{"key":"2025092002363780000_101.1.10.39","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2013.88"},{"key":"2025092002363780000_101.1.10.40","doi-asserted-by":"crossref","unstructured":"Kandzari DE, Bhatt DL, Brar S, Devireddy CM, Esler M, Fahy M, et al. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. European Heart Journal Published Online First: 16 Nov 2014 dx.doi.org\/10.1093\/eurheartj\/ehu441","DOI":"10.1093\/eurheartj\/ehu441"},{"key":"2025092002363780000_101.1.10.41","doi-asserted-by":"publisher","DOI":"10.1007\/BF00568396"},{"key":"2025092002363780000_101.1.10.42","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu195"},{"key":"2025092002363780000_101.1.10.43","unstructured":"B\u00f6hm M , Mahfoud F , Ukena C , et al . Effect of renal denervation in a real world population of patients with uncontrolled hypertension-the Global SYMPLICITY Registry. ACC Washington DC 2014; Late Breaking Clinical Trials. March 2014, DC, USA."},{"key":"2025092002363780000_101.1.10.44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1152\/physrev.1997.77.1.75","article-title":"Neural control of renal function","volume":"77","author":"DiBona","year":"1997","journal-title":"Physiol Rev"},{"key":"2025092002363780000_101.1.10.45","doi-asserted-by":"crossref","first-page":"99s","DOI":"10.1016\/S0895-7061(00)00225-9","article-title":"The sympathetic system and hypertension","volume":"13","author":"Esler","year":"2000","journal-title":"Am J Hypertens"},{"key":"2025092002363780000_101.1.10.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.10.073"},{"key":"2025092002363780000_101.1.10.47","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu093"},{"key":"2025092002363780000_101.1.10.48","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.136655"},{"key":"2025092002363780000_101.1.10.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2012.07.027"},{"key":"2025092002363780000_101.1.10.50","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV9SRA19"},{"key":"2025092002363780000_101.1.10.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.08.959"},{"key":"2025092002363780000_101.1.10.52","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.112.200865"},{"key":"2025092002363780000_101.1.10.53","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/joic.12057","article-title":"Influence of renal sympathetic denervation on quality of life","volume":"26","author":"Dorr","year":"2013","journal-title":"J Interv Cardiol"},{"key":"2025092002363780000_101.1.10.54","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2012.32"},{"key":"2025092002363780000_101.1.10.55","first-page":"646","article-title":"Real world experience of renal denervation in the United Kingdom-a two centre study","volume":"27","author":"Dasgupta","year":"2013","journal-title":"J Hum Hypertens"},{"key":"2025092002363780000_101.1.10.56","unstructured":"Caulfield M , de Belder M , Cleveland T , et al . Joint UK Societies\u2019 Consensus Summary Statement on Renal Denervation for Resistant Hypertension. 2011. http:\/\/www.bhsoc.org\/docs\/Joint-UK-Societies-Summary-on-Renal-Denervation.pdf"},{"key":"2025092002363780000_101.1.10.57","unstructured":"Excellence NIfHaC. Percutaneous transluminal radiofrequency sympathetic denervation of the renal artery for resistant hypertension. 2012. http:\/\/www.nice.org.uk\/guidance\/ipg418"},{"key":"2025092002363780000_101.1.10.58","unstructured":"NHS E . NHS England invites specialised services providers to take part in its innovative new programme \u2018Commissioning through Evaluation\u2019. 2013. http:\/\/www.england.nhs.uk\/2013\/09\/26\/com-through-eval\/"},{"key":"2025092002363780000_101.1.10.59","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328352ce78"},{"key":"2025092002363780000_101.1.10.60","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht154"},{"key":"2025092002363780000_101.1.10.61","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-013-0767-z"},{"key":"2025092002363780000_101.1.10.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.08.1616"},{"key":"2025092002363780000_101.1.10.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.04.010"},{"key":"2025092002363780000_101.1.10.64","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2013-305063"},{"key":"2025092002363780000_101.1.10.65","doi-asserted-by":"publisher","DOI":"10.1002\/ca.21280"},{"key":"2025092002363780000_101.1.10.66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.03.059"},{"key":"2025092002363780000_101.1.10.67","unstructured":"Excellence NIfHaC. Hypertension: Clinical management of primary hypertension in adults. 2011. http:\/\/www.nice.org.uk\/guidance\/cg127"},{"key":"2025092002363780000_101.1.10.68","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.02266"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2014-307029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:36:44Z","timestamp":1758361004000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2014-307029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,27]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,12]]},"published-print":{"date-parts":[[2015,1,1]]}},"alternative-id":["10.1136\/heartjnl-2014-307029"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2014-307029","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,27]]}}}